Antibiotic prescribing for acute bronchitis

Research output: Contribution to journalReviewResearchpeer-review

Standard

Antibiotic prescribing for acute bronchitis. / Llor, Carl; Bjerrum, Lars.

In: Expert Review of Anti-infective Therapy, Vol. 14, No. 7, 07.2016, p. 633-642.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Llor, C & Bjerrum, L 2016, 'Antibiotic prescribing for acute bronchitis', Expert Review of Anti-infective Therapy, vol. 14, no. 7, pp. 633-642. https://doi.org/10.1080/14787210.2016.1193435

APA

Llor, C., & Bjerrum, L. (2016). Antibiotic prescribing for acute bronchitis. Expert Review of Anti-infective Therapy, 14(7), 633-642. https://doi.org/10.1080/14787210.2016.1193435

Vancouver

Llor C, Bjerrum L. Antibiotic prescribing for acute bronchitis. Expert Review of Anti-infective Therapy. 2016 Jul;14(7):633-642. https://doi.org/10.1080/14787210.2016.1193435

Author

Llor, Carl ; Bjerrum, Lars. / Antibiotic prescribing for acute bronchitis. In: Expert Review of Anti-infective Therapy. 2016 ; Vol. 14, No. 7. pp. 633-642.

Bibtex

@article{e472ef6213844df586bc24160f5689bf,
title = "Antibiotic prescribing for acute bronchitis",
abstract = "INTRODUCTION: Acute bronchitis is a self-limiting infectious disease characterized by acute cough with or without sputum but without signs of pneumonia. About 90{\%} of cases are caused by viruses.AREAS COVERED: Antibiotics for acute bronchitis have been associated with an approximately half-day reduction in duration of cough. However, at follow-up there are no significant differences in overall clinical improvement inpatients treated with antibiotics compared with those receiving placebo. Despite this, antibiotics are administered to approximately two thirds of these patients. This review discusses the reason for this antibiotic overprescription. Other therapies targeted to control symptoms have also demonstrated a marginal or no effect. EXPERT COMMENTARY: Clinicians should be aware of the marginal effectiveness of antibiotic therapy. Some strategies like the use of rapid tests, delayed prescribing of antibiotics and the use of leaflets for patients have been associated with a reduction of their unnecessary utilization.",
keywords = "Journal Article",
author = "Carl Llor and Lars Bjerrum",
year = "2016",
month = "7",
doi = "10.1080/14787210.2016.1193435",
language = "English",
volume = "14",
pages = "633--642",
journal = "Expert Review of Anti-infective Therapy",
issn = "1478-7210",
publisher = "Taylor & Francis",
number = "7",

}

RIS

TY - JOUR

T1 - Antibiotic prescribing for acute bronchitis

AU - Llor, Carl

AU - Bjerrum, Lars

PY - 2016/7

Y1 - 2016/7

N2 - INTRODUCTION: Acute bronchitis is a self-limiting infectious disease characterized by acute cough with or without sputum but without signs of pneumonia. About 90% of cases are caused by viruses.AREAS COVERED: Antibiotics for acute bronchitis have been associated with an approximately half-day reduction in duration of cough. However, at follow-up there are no significant differences in overall clinical improvement inpatients treated with antibiotics compared with those receiving placebo. Despite this, antibiotics are administered to approximately two thirds of these patients. This review discusses the reason for this antibiotic overprescription. Other therapies targeted to control symptoms have also demonstrated a marginal or no effect. EXPERT COMMENTARY: Clinicians should be aware of the marginal effectiveness of antibiotic therapy. Some strategies like the use of rapid tests, delayed prescribing of antibiotics and the use of leaflets for patients have been associated with a reduction of their unnecessary utilization.

AB - INTRODUCTION: Acute bronchitis is a self-limiting infectious disease characterized by acute cough with or without sputum but without signs of pneumonia. About 90% of cases are caused by viruses.AREAS COVERED: Antibiotics for acute bronchitis have been associated with an approximately half-day reduction in duration of cough. However, at follow-up there are no significant differences in overall clinical improvement inpatients treated with antibiotics compared with those receiving placebo. Despite this, antibiotics are administered to approximately two thirds of these patients. This review discusses the reason for this antibiotic overprescription. Other therapies targeted to control symptoms have also demonstrated a marginal or no effect. EXPERT COMMENTARY: Clinicians should be aware of the marginal effectiveness of antibiotic therapy. Some strategies like the use of rapid tests, delayed prescribing of antibiotics and the use of leaflets for patients have been associated with a reduction of their unnecessary utilization.

KW - Journal Article

U2 - 10.1080/14787210.2016.1193435

DO - 10.1080/14787210.2016.1193435

M3 - Review

C2 - 27219826

VL - 14

SP - 633

EP - 642

JO - Expert Review of Anti-infective Therapy

JF - Expert Review of Anti-infective Therapy

SN - 1478-7210

IS - 7

ER -

ID: 165878369